(BUFS) BUFS - Ratings and Ratios

Exchange: BATS • Country: USA • Currency: USD • Type: Etf • ISIN: (N/A)

Options, ETF, FLEX, Russell 2000, Portfolio, Outcomes

Description: BUFS BUFS

The Innovator S&P Small-Cap Buffer ETF - September (BUFS) employs a laddered portfolio strategy, investing in a series of underlying ETFs with staggered target outcome periods. This approach allows the fund to maintain a consistent level of exposure to the iShares Russell 2000 ETF (IWM) through FLexible EXchange Options (FLEX Options), which are customized, exchange-traded options backed by the Options Clearing Corporation. As a non-diversified fund, BUFS concentrates its investments, amplifying potential gains and losses.

BUFS is categorized as a Defined Outcome ETF, indicating its investment objective is to achieve a predetermined outcome, in this case, providing a buffer against potential losses in the underlying IWM ETF. The funds structure suggests it is designed for investors seeking to manage risk while still participating in potential market gains.

Analyzing the available data, we observe that BUFS has a relatively stable price action, with its 20-day and 50-day Simple Moving Averages (SMA) indicating a slight uptrend. The Average True Range (ATR) of 0.31, representing 1.52% of the last price, suggests moderate volatility. Given the current price of $20.68, the 52-week range of $18.82 to $22.15, and the SMA200 at $20.98, we can infer that the ETF is currently trading near its longer-term mean.

Considering both technical and fundamental data, a forecast for BUFS can be constructed. With the AUM at $87.51M, the fund has a reasonable size to maintain liquidity. The technical indicators suggest a potential for continued stability or slight growth, given the SMA20 and SMA50 are trending upwards. However, the proximity to the SMA200 may indicate a potential resistance level. If the IWM continues to perform well and the overall market remains stable, BUFS could potentially move towards its 52-week high. Conversely, a downturn could see it buffered by its defined outcome strategy. A likely forecast is that BUFS will continue to trade within a narrow range, potentially testing the $21.00 level in the near term, assuming the underlying IWM ETF remains stable and the overall market conditions do not drastically change.

Additional Sources for BUFS ETF

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle

BUFS ETF Overview

Market Cap in USD 84m
Category Defined Outcome
IPO / Inception 2024-05-29

BUFS ETF Ratings

Growth Rating 14.2
Fundamental -
Dividend Rating 0.0
Rel. Strength -7.05
Analysts -
Fair Price Momentum 18.75 USD
Fair Price DCF -

BUFS Dividends

Currently no dividends paid

BUFS Growth Ratios

Growth Correlation 3m 90.7%
Growth Correlation 12m -14.3%
Growth Correlation 5y 4%
CAGR 5y 6.33%
CAGR/Max DD 5y 0.42
Sharpe Ratio 12m 0.45
Alpha -3.49
Beta 0.561
Volatility 10.77%
Current Volume 26k
Average Volume 20d 23.2k
What is the price of BUFS shares?
As of July 02, 2025, the stock is trading at USD 21.19 with a total of 26,049 shares traded.
Over the past week, the price has changed by +1.03%, over one month by +3.50%, over three months by +4.49% and over the past year by +6.59%.
Is BUFS a good stock to buy?
Neither. Based on ValueRay´s Analyses, BUFS is currently (July 2025) neither a good nor a bad stock to buy. It has a ValueRay Growth Rating of 14.21 and therefor a technical neutral rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of BUFS is around 18.75 USD . This means that BUFS is currently overvalued and has a potential downside of -11.51%.
Is BUFS a buy, sell or hold?
BUFS has no consensus analysts rating.
What are the forecasts for BUFS share price target?
According to our own proprietary Forecast Model, BUFS BUFS will be worth about 21.2 in July 2026. The stock is currently trading at 21.19. This means that the stock has a potential downside of -0.14%.
Issuer Target Up/Down from current
Wallstreet Target Price - -
Analysts Target Price - -
ValueRay Target Price 21.2 -0.1%